Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.
| Autor: | Gish RG, Porta C, Lazar L, Ruff P, Feld R, Croitoru A, Feun L, Jeziorski K, Leighton J, Gallo J, Kennealey GT |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 7/20/2007, Vol. 25 Issue 21, p3069-3075, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|